当前位置: 首页 > 期刊 > 《中国医学创新》 > 2014年第9期 > 正文
编号:12706159
NDV7793促进人CD4+T细胞表达TRAIL的实验研究(3)
http://www.100md.com 2014年3月25日 樊晓晖等
第1页

    参见附件。

     [3] Schirrmacher V.T cell-mediated immunotherapy of metastases: state of the art in 2005[J].Expert Opin Biol Ther,2005,5(8):1051-1068.

    [4] Schirrmacher V,Griesbach A,Ahlert T.Antitumor effects of newcastle disease virus in vivo: local versus systemic effects[J].Int J Oncol,2001,18(5):945-952.

    [5]殷君,王立芳,樊晓晖,等.新城疫病毒对人NK细胞表达TRAIL的促进作用[J].肿瘤,2012,32(12):974-981.

    [6] Wilden H,Schirrmacher V,Fournier P.Important role of interferon regulatory factor (IRF) -3 in the interferon response of mouse macrophages upon IFNection by Newcastle disease virus[J].Int J Oncol,2011,39(2):493-504.

    [7] Fournier P,Arnold A,Schirrmacher V.Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus[J].J Buon,2009,14(1):11-22.

    [8] Fournier P,Schirrmacher V.Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future[J].Bio Drugs,2013,27(1):35-53.

    [9] Brown D M.Cytolytic CD4 cells: direct mediators in infectious disease and malignancy[J].Cell Immunol,2010,262(2):89-95.

    [10] Ashkenazi A,Pai R C,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand[J].The Journal of clinical investigation,1999,104(2):155-162.

    [11]郝景波,王文飞,吴云舟,等.重组新城疫病毒Anhinga株与TRAIL蛋白协同杀伤肿瘤细胞[J].中国生物化学分子生物学报,2011,27(1):32-39.

    (收稿日期:2014-02-19) (本文编辑:蔡元元)

您现在查看是摘要介绍页,详见PDF附件